 |
Multiple Sclerosis - Medications
glatiramer (Copaxone® ) |
|
Indications: reduction of the frequency of
relapses in patients with Relapsing-Remitting Multiple Sclerosis. Dosing (Adults): (usual) Multiple sclerosis: 20 mg SC daily. ADMINISTRATION — For SubQ administration in the arms, abdomen, hips or thighs. Bring to room temperature prior to use. |
interferon beta-1A (Avonex ® , Rebif ® ) |
|
AVONEX® (Interferon beta-1a) is indicated for the treatment of relapsing
forms of multiple sclerosis to slow the accumulation of physical
disability and decrease the frequency of clinical exacerbations. Safety
and efficacy in patients with chronic progressive multiple sclerosis
have not been evaluated. Recommended dosage: 30 mcg injected intramuscularly once a week. |
interferon beta-1B (Betaseron ®) |
|
Betaseron is indicated for use in ambulatory patients with
relapsing-remitting multiple sclerosis to reduce the frequency of
clinical exacerbations. Relapsing-remitting MS is characterized by
recurrent attacks of neurologic dysfunction followed by complete or
incomplete recovery. The safety and efficacy of Betaseron in
chronic-progressive MS has not been evaluated. Recommended dose: 0.25 mg injected subcutaneously every other day. |
 |
Disclaimer |
|
Listed dosages are for - Adult patients ONLY. PLEASE READ THE
DISCLAIMER CAREFULLY BEFORE
ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE
TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.
GlobalRPH does not directly or indirectly practice medicine or provide
medical services and therefore assumes no liability whatsoever of any
kind for the information and data accessed through the Service or for
any diagnosis or treatment made in reliance thereon. David F. McAuley, Pharm.D., R.Ph. GlobalRPh Inc. |
| Disclaimer Contact Us Privacy Policy Website Search | We comply with the HONcode standard for health trustworthy information: Verify here. Copyright © 2007 GlobalRPh Inc. |
 |
 |